Showing results (21-30 of 127) with videos related to
Sort By:
Pageof 13
Scientific Reports|March 19, 2021
Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostateSophie N Lee, Jenna Kraska, Melissa Papargiris, et al.Cold Spring Harbor Perspectives in Medicine|January 10, 2018
Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant ModelsGail P Risbridger, Roxanne Toivanen, Renea A TaylorEndocrine-Related Cancer|July 28, 2010
Stem cells in prostate cancer: treating the root of the problemRenea A Taylor, Roxanne Toivanen, Gail P RisbridgerThe Journal of Endocrinology|January 11, 2023
Advances in preclinical models of prostate cancer for research discoveryRenea A Taylor, Mitchell G Lawrence, Gail P RisbridgerCytokine & Growth Factor Reviews|June 1, 2005
Should activin betaC be more than a fading snapshot in the activin/TGFbeta family album?Christopher M Butler, Elspeth J Gold, Gail P RisbridgerJournal of the Endocrine Society|October 23, 2020
PDX: Moving Beyond Drug Screening to Versatile Models for Research DiscoveryGail P Risbridger, Mitchell G Lawrence, Renea A TaylorCytokine & Growth Factor Reviews|September 29, 2004
Cancer progression: is inhibin alpha from Venus or Mars?Emma M A Ball, Sally L Mellor, Gail P RisbridgerZhonghua Yi Xue Za Zhi|October 30, 2010
[Establishment of a xenograft model of human prostate cancer in mouse]Hong-bin Sun, Hong Wang, Renea A Taylor, et al.Nature Reviews. Cancer|February 12, 2010
Breast and prostate cancer: more similar than differentGail P Risbridger, Ian D Davis, Stephen N Birrell, et al.Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.Pageof 13